QUEST DIAGNOSTICS INC 4

Sam Samad, EVP & CFO of Quest Diagnostics Inc. (DGX), acquired 102 shares of common stock via a dividend reinvestment/RSU-related award on 2026-07-22.

On July 22, 2026, Sam Samad, Executive Vice President & CFO of Quest Diagnostics Inc., reported an acquisition of 102 shares of common stock via a dividend reinvestment plan, which the filer characterizes as an award of restricted share units and has voluntarily reported early on Form 4 even though it would have been eligible for deferred reporting on Form 5 under Rule 16a-6. The shares were acquired at an implied price of approximately $206.81 per share, bringing the filer’s direct ownership to 33,478 shares following the transaction. Based on the current market price of about $230.39, the filer’s post-transaction holdings are worth an estimated $7.7 million, indicating a substantial existing equity stake while the newly reported transaction itself is relatively small and routine in dollar terms.

Filing Facts

CIK

1022079

Ticker

DGX

Form

4

Source Type

sec

Accession

0001022079-26-000081

Alert Tier

4